Global (United States, European Union and China) Pharmaceutical Hot Melt Extrusion

Pharmaceutical Hot Melt Extrusion Comprehensive Study by Type (Single Screw Extruder, Twin Screw Extruder, Laboratory Extruder, RAM Extruder), End User (Research Laboratory, Contract Manufacturing Organization, Pharma Companies) Players and Region - Global Market Outlook to 2026

Pharmaceutical Hot Melt Extrusion Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Pharmaceutical Hot Melt Extrusion?
Hot melt extrusion (HME) is the processing of applying heat and pressure to melt a polymer and processed for mixing of thermoplastic binders and active compounds. This process is mainly for the production of binders with uniform shape and density. It is widely used in pharmaceutical and medical devices industry to produce mix active pharmaceutical ingredients (APIs) and medical devices. This process helps to enhance the bioavailability of API’s by masking its bitter taste. Further it prepares precursors for thermoplastic drug-eluting devices. Hence, it is mainly essential for manufacturing of subcutaneous and intraocular implants and intravaginal rings. Hot melt extrusion technique is utilized in the enhancement of active pharmaceutical ingredients bioavailability. Thus, owing to this raised applications in pharmaceutical industry, the demand for the hot melt extrusion has been increased. Raised pharmaceutical expenditure providing growth opportunity to the market. However, increasing concern regarding limitations like least adherence to certain material and stringent regulations may impact on the market in negative manner. Geographically, North America is anticipated to dominate the market followed by Europe. In North America, well established expenditure of pharmaceutical industry, presence of several key market players and rapid adoption of advanced technologies is mainly responsible for the dominance of the North America.

The market study is broken down by Type (Single Screw Extruder, Twin Screw Extruder, Laboratory Extruder and RAM Extruder) and major geographies with country level break-up.

There are various companies are operating in the market to provide hot melt extrusion processes. Increased demand for use in pharmaceutical industry is impacting on the demand for hot melt extrusion processes in positive manner. Hence to grab the opportunity associated with the market, many new market players are entering to the market. The market leaders are investing on organic and non-organic strategic growth initiatives to become dominant in this industry. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Foster Corporation. (United States), Nordson Corporation (United States), AbbVie Inc. (United States), Thermo Fisher Scientific Inc. (United States), Corning Life Sciences(United States), Coperion GmbH (Germany), Gebrüder Lödige Maschinenbau GmbH (Germany), Hovione(Portugal), UMANG PHARMATECH PVT. LTD. (India), Baker Perkins Ltd. (United Kingdom), Gabler GmbH & Co. KG (Germany) and Leistritz Advanced Technologies Corp. (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Pharmaceutical Hot Melt Extrusion market by Type, Application and Region.

On the basis of geography, the market of Pharmaceutical Hot Melt Extrusion has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Research Laboratory will boost the Pharmaceutical Hot Melt Extrusion market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.




Market Trend
  • Augmented Pharmaceutical Industry Expenditure

Market Drivers
  • Hot Melt Extrusion Reduces Manufacturing Costs Which Is Mainly Responsible For the Raised Demand
  • Decreases the Risk of Human Error & Improves Quality Drives the Demand for the Hot Melt Extrusion

Opportunities
  • Technological Advancements Is Hot Melt Extrusion Process Is Providing Opportunity for Quicker and Errorless Production

Restraints
  • Limitations for Small Scale Pharmaceutical Companies

Challenges
  • High Capital Investments for Installation Process


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Strategic Business Planners, Pharmaceutical Companies, Government Regulatory, Research Organizations and End-Use Industries

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Single Screw Extruder
  • Twin Screw Extruder
  • Laboratory Extruder
  • RAM Extruder
By End User
  • Research Laboratory
  • Contract Manufacturing Organization
  • Pharma Companies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Hot Melt Extrusion Reduces Manufacturing Costs Which Is Mainly Responsible For the Raised Demand
      • 3.2.2. Decreases the Risk of Human Error & Improves Quality Drives the Demand for the Hot Melt Extrusion
    • 3.3. Market Challenges
      • 3.3.1. High Capital Investments for Installation Process
    • 3.4. Market Trends
      • 3.4.1. Augmented Pharmaceutical Industry Expenditure
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmaceutical Hot Melt Extrusion, by Type, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Pharmaceutical Hot Melt Extrusion (Value)
      • 5.2.1. Global Pharmaceutical Hot Melt Extrusion by: Type (Value)
        • 5.2.1.1. Single Screw Extruder
        • 5.2.1.2. Twin Screw Extruder
        • 5.2.1.3. Laboratory Extruder
        • 5.2.1.4. RAM Extruder
      • 5.2.2. Global Pharmaceutical Hot Melt Extrusion by: End User (Value)
        • 5.2.2.1. Research Laboratory
        • 5.2.2.2. Contract Manufacturing Organization
        • 5.2.2.3. Pharma Companies
      • 5.2.3. Global Pharmaceutical Hot Melt Extrusion Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Pharmaceutical Hot Melt Extrusion: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Foster Corporation. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Nordson Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. AbbVie Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Thermo Fisher Scientific Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Corning Life Sciences(United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Coperion GmbH (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Gebrüder Lödige Maschinenbau GmbH (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Hovione(Portugal)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. UMANG PHARMATECH PVT. LTD. (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Baker Perkins Ltd. (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Gabler GmbH & Co. KG (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Leistritz Advanced Technologies Corp. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Pharmaceutical Hot Melt Extrusion Sale, by Type, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Pharmaceutical Hot Melt Extrusion (Value)
      • 7.2.1. Global Pharmaceutical Hot Melt Extrusion by: Type (Value)
        • 7.2.1.1. Single Screw Extruder
        • 7.2.1.2. Twin Screw Extruder
        • 7.2.1.3. Laboratory Extruder
        • 7.2.1.4. RAM Extruder
      • 7.2.2. Global Pharmaceutical Hot Melt Extrusion by: End User (Value)
        • 7.2.2.1. Research Laboratory
        • 7.2.2.2. Contract Manufacturing Organization
        • 7.2.2.3. Pharma Companies
      • 7.2.3. Global Pharmaceutical Hot Melt Extrusion Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmaceutical Hot Melt Extrusion: by Type(USD Million)
  • Table 2. Pharmaceutical Hot Melt Extrusion Single Screw Extruder , by Region USD Million (2015-2020)
  • Table 3. Pharmaceutical Hot Melt Extrusion Twin Screw Extruder , by Region USD Million (2015-2020)
  • Table 4. Pharmaceutical Hot Melt Extrusion Laboratory Extruder , by Region USD Million (2015-2020)
  • Table 5. Pharmaceutical Hot Melt Extrusion RAM Extruder , by Region USD Million (2015-2020)
  • Table 6. Pharmaceutical Hot Melt Extrusion: by End User(USD Million)
  • Table 7. Pharmaceutical Hot Melt Extrusion Research Laboratory , by Region USD Million (2015-2020)
  • Table 8. Pharmaceutical Hot Melt Extrusion Contract Manufacturing Organization , by Region USD Million (2015-2020)
  • Table 9. Pharmaceutical Hot Melt Extrusion Pharma Companies , by Region USD Million (2015-2020)
  • Table 10. South America Pharmaceutical Hot Melt Extrusion, by Country USD Million (2015-2020)
  • Table 11. South America Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 12. South America Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 13. Brazil Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 14. Brazil Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 15. Argentina Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 16. Argentina Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 17. Rest of South America Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 18. Rest of South America Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 19. Asia Pacific Pharmaceutical Hot Melt Extrusion, by Country USD Million (2015-2020)
  • Table 20. Asia Pacific Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 21. Asia Pacific Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 22. China Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 23. China Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 24. Japan Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 25. Japan Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 26. India Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 27. India Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 28. South Korea Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 29. South Korea Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 30. Taiwan Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 31. Taiwan Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 32. Australia Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 33. Australia Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 34. Rest of Asia-Pacific Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 35. Rest of Asia-Pacific Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 36. Europe Pharmaceutical Hot Melt Extrusion, by Country USD Million (2015-2020)
  • Table 37. Europe Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 38. Europe Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 39. Germany Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 40. Germany Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 41. France Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 42. France Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 43. Italy Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 44. Italy Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 45. United Kingdom Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 46. United Kingdom Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 47. Netherlands Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 48. Netherlands Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 49. Rest of Europe Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 50. Rest of Europe Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 51. MEA Pharmaceutical Hot Melt Extrusion, by Country USD Million (2015-2020)
  • Table 52. MEA Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 53. MEA Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 54. Middle East Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 55. Middle East Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 56. Africa Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 57. Africa Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 58. North America Pharmaceutical Hot Melt Extrusion, by Country USD Million (2015-2020)
  • Table 59. North America Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 60. North America Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 61. United States Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 62. United States Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 63. Canada Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 64. Canada Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 65. Mexico Pharmaceutical Hot Melt Extrusion, by Type USD Million (2015-2020)
  • Table 66. Mexico Pharmaceutical Hot Melt Extrusion, by End User USD Million (2015-2020)
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Pharmaceutical Hot Melt Extrusion: by Type(USD Million)
  • Table 80. Pharmaceutical Hot Melt Extrusion Single Screw Extruder , by Region USD Million (2021-2026)
  • Table 81. Pharmaceutical Hot Melt Extrusion Twin Screw Extruder , by Region USD Million (2021-2026)
  • Table 82. Pharmaceutical Hot Melt Extrusion Laboratory Extruder , by Region USD Million (2021-2026)
  • Table 83. Pharmaceutical Hot Melt Extrusion RAM Extruder , by Region USD Million (2021-2026)
  • Table 84. Pharmaceutical Hot Melt Extrusion: by End User(USD Million)
  • Table 85. Pharmaceutical Hot Melt Extrusion Research Laboratory , by Region USD Million (2021-2026)
  • Table 86. Pharmaceutical Hot Melt Extrusion Contract Manufacturing Organization , by Region USD Million (2021-2026)
  • Table 87. Pharmaceutical Hot Melt Extrusion Pharma Companies , by Region USD Million (2021-2026)
  • Table 88. South America Pharmaceutical Hot Melt Extrusion, by Country USD Million (2021-2026)
  • Table 89. South America Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 90. South America Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 91. Brazil Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 92. Brazil Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 93. Argentina Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 94. Argentina Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 95. Rest of South America Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 96. Rest of South America Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 97. Asia Pacific Pharmaceutical Hot Melt Extrusion, by Country USD Million (2021-2026)
  • Table 98. Asia Pacific Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 99. Asia Pacific Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 100. China Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 101. China Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 102. Japan Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 103. Japan Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 104. India Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 105. India Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 106. South Korea Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 107. South Korea Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 108. Taiwan Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 109. Taiwan Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 110. Australia Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 111. Australia Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 112. Rest of Asia-Pacific Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 113. Rest of Asia-Pacific Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 114. Europe Pharmaceutical Hot Melt Extrusion, by Country USD Million (2021-2026)
  • Table 115. Europe Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 116. Europe Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 117. Germany Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 118. Germany Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 119. France Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 120. France Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 121. Italy Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 122. Italy Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 123. United Kingdom Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 124. United Kingdom Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 125. Netherlands Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 126. Netherlands Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 127. Rest of Europe Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 128. Rest of Europe Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 129. MEA Pharmaceutical Hot Melt Extrusion, by Country USD Million (2021-2026)
  • Table 130. MEA Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 131. MEA Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 132. Middle East Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 133. Middle East Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 134. Africa Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 135. Africa Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 136. North America Pharmaceutical Hot Melt Extrusion, by Country USD Million (2021-2026)
  • Table 137. North America Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 138. North America Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 139. United States Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 140. United States Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 141. Canada Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 142. Canada Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 143. Mexico Pharmaceutical Hot Melt Extrusion, by Type USD Million (2021-2026)
  • Table 144. Mexico Pharmaceutical Hot Melt Extrusion, by End User USD Million (2021-2026)
  • Table 145. Research Programs/Design for This Report
  • Table 146. Key Data Information from Secondary Sources
  • Table 147. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmaceutical Hot Melt Extrusion: by Type USD Million (2015-2020)
  • Figure 5. Global Pharmaceutical Hot Melt Extrusion: by End User USD Million (2015-2020)
  • Figure 6. South America Pharmaceutical Hot Melt Extrusion Share (%), by Country
  • Figure 7. Asia Pacific Pharmaceutical Hot Melt Extrusion Share (%), by Country
  • Figure 8. Europe Pharmaceutical Hot Melt Extrusion Share (%), by Country
  • Figure 9. MEA Pharmaceutical Hot Melt Extrusion Share (%), by Country
  • Figure 10. North America Pharmaceutical Hot Melt Extrusion Share (%), by Country
  • Figure 11. Global Pharmaceutical Hot Melt Extrusion share by Players 2020 (%)
  • Figure 12. Global Pharmaceutical Hot Melt Extrusion share by Players (Top 3) 2020(%)
  • Figure 13. Global Pharmaceutical Hot Melt Extrusion share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Foster Corporation. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Foster Corporation. (United States) Revenue: by Geography 2020
  • Figure 17. Nordson Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Nordson Corporation (United States) Revenue: by Geography 2020
  • Figure 19. AbbVie Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. AbbVie Inc. (United States) Revenue: by Geography 2020
  • Figure 21. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2020
  • Figure 23. Corning Life Sciences(United States) Revenue, Net Income and Gross profit
  • Figure 24. Corning Life Sciences(United States) Revenue: by Geography 2020
  • Figure 25. Coperion GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Coperion GmbH (Germany) Revenue: by Geography 2020
  • Figure 27. Gebrüder Lödige Maschinenbau GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Gebrüder Lödige Maschinenbau GmbH (Germany) Revenue: by Geography 2020
  • Figure 29. Hovione(Portugal) Revenue, Net Income and Gross profit
  • Figure 30. Hovione(Portugal) Revenue: by Geography 2020
  • Figure 31. UMANG PHARMATECH PVT. LTD. (India) Revenue, Net Income and Gross profit
  • Figure 32. UMANG PHARMATECH PVT. LTD. (India) Revenue: by Geography 2020
  • Figure 33. Baker Perkins Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Baker Perkins Ltd. (United Kingdom) Revenue: by Geography 2020
  • Figure 35. Gabler GmbH & Co. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Gabler GmbH & Co. KG (Germany) Revenue: by Geography 2020
  • Figure 37. Leistritz Advanced Technologies Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Leistritz Advanced Technologies Corp. (United States) Revenue: by Geography 2020
  • Figure 39. Global Pharmaceutical Hot Melt Extrusion: by Type USD Million (2021-2026)
  • Figure 40. Global Pharmaceutical Hot Melt Extrusion: by End User USD Million (2021-2026)
  • Figure 41. South America Pharmaceutical Hot Melt Extrusion Share (%), by Country
  • Figure 42. Asia Pacific Pharmaceutical Hot Melt Extrusion Share (%), by Country
  • Figure 43. Europe Pharmaceutical Hot Melt Extrusion Share (%), by Country
  • Figure 44. MEA Pharmaceutical Hot Melt Extrusion Share (%), by Country
  • Figure 45. North America Pharmaceutical Hot Melt Extrusion Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Foster Corporation. (United States)
  • Nordson Corporation (United States)
  • AbbVie Inc. (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • Corning Life Sciences(United States)
  • Coperion GmbH (Germany)
  • Gebrüder Lödige Maschinenbau GmbH (Germany)
  • Hovione(Portugal)
  • UMANG PHARMATECH PVT. LTD. (India)
  • Baker Perkins Ltd. (United Kingdom)
  • Gabler GmbH & Co. KG (Germany)
  • Leistritz Advanced Technologies Corp. (United States)
Select User Access Type

Key Highlights of Report


Oct 2021 200 Pages 88 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global (United States, European Union and China) Pharmaceutical Hot Melt Extrusion Quantitative research analysis
Global (United States, European Union and China) Pharmaceutical Hot Melt Extrusion Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Foster Corporation. (United States), Nordson Corporation (United States), AbbVie Inc. (United States), Thermo Fisher Scientific Inc. (United States), Corning Life Sciences(United States), Coperion GmbH (Germany), Gebrüder Lödige Maschinenbau GmbH (Germany), Hovione(Portugal), UMANG PHARMATECH PVT. LTD. (India), Baker Perkins Ltd. (United Kingdom), Gabler GmbH & Co. KG (Germany) and Leistritz Advanced Technologies Corp. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Analysts at AMA estimates Pharmaceutical Hot Melt Extrusion Market to reach USD Million by 2026.

Know More About Global (United States, European Union and China) Pharmaceutical Hot Melt Extrusion Report?

Have a Query? Click Here

Other Related Reports

Necrotizing Fasciitis Comprehensive Study by Application (Hospital & Clinics, Surgical Centers), Treatment (Surgical debridement, Antibiotics, Amputation), Diagnosis (Clinical examination, Blood and ...
$ 3800
Colorectal Cancer Drugs Comprehensive Study by Application (Radiotherapy, Chemotherapy), Drug Type (Bevacizumab, Irinotecan Hydrochloride, Capecitabine, Cetuximab, Ramucirumab, Oxaliplatin, Cetuximab...
$ 3650
Endometriosis Drugs Comprehensive Study by Application (Hospitals, Clinics, Research Institutes, Others), Route of Administration (Oral, Nasal Spray, Intrauterine Systems, Parenteral), Therapy Type (...
$ 3750
Azacitidine Drug Comprehensive Study by Type (Acute myeloid leukemia (AML), Myelodysplastic syndrome (MDS)), Application (Refractory anemia (RA), Refractory anemia with excess blasts (RAEB), Chronic ...
$ 3750
Angina Pectoris Drugs Comprehensive Study by Type (Nitrates, Non-Steroidal Anti-Inflammatory Drugs, Anti-Platelet Drugs, Beta Blockers, Statins, Calcium Antagonists, Angiotensin-Converting Enzyme (Ac...
$ 3750
Polymixin Comprehensive Study by Type (Polymyxin B, Polymyxin E), Application (Humans, Veterinary {Pigs, Poultry, Cattle, Sheep, Goats, Rabbits, and Others}), Administration Route (Oral, Injection) P...
$ 3500